Myths and Realities of Personalised Medicine: the Genetic Revolution (FutureLearn)
Categories
Effort
Languages
No sessions available
Sheri Nixdorf
Dr Nixdorf is a member of The Australian Society for Medical Research, Cancer Voices NSW and the Translational Cancer Research Network in order to share medical advances with the community and speed up the collaborative process of ‘bench to bedside’ treatments for cancer patients.
Research Interests:
Ovarian Cancer is called a 'silent killer' because of the non-specific symptoms and thus late detection of this disease. Therefore, identification of novel tumour markers for diagnosis and prognosis of Ovarian Cancer comprises the main focus of research efforts. Discovery of sensitive and specific biomarkers for Ovarian Cancer involves collaborations with hospitals and other research institutes, both locally and internationally. Glycan arrays are utilised to screen serum samples from Ovarian Cancer patients and isolate potential biomarkers of disease.
More info here.